Pioneers of Portable IORT
IntraOp is the pioneer in portable electron-based Intraoperative Radiation Therapy (IORT). Since introducing the Mobetron in 1993, IntraOp has transformed cancer treatment by bringing the only safe, reliable self-shielded radiation technology into the operating room. The use of electrons in IORT enables surgical and radiation oncologists to deliver a precise and targeted dose of controlled radiation during surgery to locally-advanced cancers. For patients and their families, it means markedly shorter treatment and recovery times with improved cosmesis, greater comfort and quality of life. At IntraOp, we are accelerating the cure.
For more than 20 years, we have been perfecting this technology to dramatically reduce radiation treatment times, cost and reoccurrence rates while improving cosmetic results and patient survivability.
Our flagship product—the Mobetron—is used by many of the leading cancer physicians in the best hospitals, clinics and academic centers in the world.
The Mobetron is the first mobile, self-shielded—no additional OR or special shielding is required—electron linear accelerator designed to deliver Intraoperative Radiation Therapy (IORT) to cancer patients during surgery. Consider the scene before the Mobetron: A patient undergoing surgery is required transport to a shielded radiation bunker only to be returned after treatment for the remainder of the surgery. The method was inefficient for oncologists and added costs for the hospital. Worse, it introduced greater risk for the patient.
Fast forward. By making electrons portable, the Mobetron leverages the advantages of IORT without sacrificing effectiveness. Radiation and surgical oncologists are now enabled to work together to pinpoint the exact area requiring radiation and immediately deliver high doses directly to the affected tissue during cancer surgery. Healthy tissue and surrounding organs remain unaffected. Portability means that the Mobetron can easily be moved between existing operating rooms without investing in costly renovations to accommodate traditional unshielded radiation therapy devices.
The treatment is brought to the patient. The procedure is completed in a fraction of the time with fewer side effects and lower rates of recurrence. Most importantly, the patient can go on living. Longer.